Mayne Pharma
Nicki Carter has a diverse work experience spanning over two decades. Nicki started their career as a Laboratory Technician at the Australian Government Analytical Laboratories in 1996 and worked there until 1997. In 1998, they joined Mayne Pharma as a QC Chemist and held this position till 2004. Nicki then advanced to the role of Senior QC Chemist from 2005 to 2010, followed by the position of QC Systems Coordinator from 2010 to 2019. From 2019 to 2023, they served as the QC Systems & Training Coordinator at Mayne Pharma. Currently, they hold the position of Operations Training Lead at the company.
Nicki Carter obtained a Bachelor of Science (hons) degree in Organic Chemistry from the University of Adelaide between 1990 and 1994. Additionally, they completed a Certificate IV in Workplace Training & Assessment from Business SA. Nicki also pursued New Supervisor Management at the Australian Institute of Management, although the exact dates of completion are not provided.
This person is not in any teams
Mayne Pharma
1 followers
Mayne Pharma Group Ltd is an Australia-based specialty pharmaceutical company. The Company is focused on commercializing branded and generic pharmaceuticals. It operates through four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.